从K/DOQI 2002到KDIGO 2012慢性肾脏疾病诊疗指南中实验室检测项目相关应用建议的解读  

Updates for clinical laboratories from K/DOQI 2002 to KDIGO 2012 clinical practice guidelines for chronic kidney disease

作　　者：郭玮[1] 潘柏申[1] 

机构地区：[1]复旦大学附属中山医院检验科,上海200032

出　　处：《检验医学》2015年第7期663-667,662,共5页Laboratory Medicine

摘　　要：慢性肾脏疾病(CKD)已经成为为全球关注的公共卫生问题。2002年美国国家肾脏基金会(NKF)所属的"肾脏病预后质量倡议(K/DOQI)"工作组发布的"慢性肾脏疾病的评估、分期的临床实践诊疗指南"明确了CKD定义,制订了CKD分期评估与管理的概念性框架。"肾脏疾病·改善全球预后(KDIGO)"组织2012年发布的"慢性肾脏疾病评估和管理的临床实践诊疗指南"立足于循证医学证据评估,对K/DOQI 2002指南进行了完善和讨论,并且针对实验室人员以及检测项目提出建议。文章重点介绍了指南中的更新进展以及实验室检测相关应用建议,以便实验室工作人员更好地理解指南中的建议以及在临床工作中的应用。Chronic kidney disease（ CKD） has been recognized as global public healthy problem. In 2002,Clinical Practice Guidelines for Chronic Kidney Disease： Evaluation,Classification,and Stratification of the Kidney Disease Out-comes Quality Initiative（ K / DOQI） from the National Kidney Foundation（ NKF） established the definition and framework for the evaluation and management of CKD. In 2012,Clinical Practice Guidelines for Evalution and Management of Chronic Kidney Disease of the Kidney Disease · Improving Global Outcomes（ KDIGO） updated and developed an explicit process of evidence review and appraisal,specifically including recommendations for clinical laboratories. This paper reviews the update progress and focuses on clinical laboratory sections in order to learn from the guidelines as well as apply in clinical practice better.

关 键 词：慢性肾脏疾病 临床实践指南 

分 类 号：R692[医药卫生—泌尿科学]